Jasmonates: Novel Anticancer Agents Acting Directly and Selectively on Human Cancer Cell Mitochondria

Ronit Rotem, Alina Heyfets, Orit Fingrut, +3

Cancer Research

Protein disulfide isomerase mediates integrin‐dependent adhesion

Judith Lahav, N. Gofer-Dadosh, Jacob Luboshitz, +2

FEBS Letters

Gaucher's disease: a disease with chronic stimulation of the immune system.

Yehuda Shoenfeld, LETITIA GALLANT, Mati Shaklai, +3

PubMed

ImmunohematologyPolyclonal ImmunoglobulinsImmunodeficienciesImmunologyPathology +17

Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma

Osnat Bairey, Israel Kremer, Erica Rakowsky, +2

Cancer

Expression of p53 in human leukemia and lymphoma

Miron Prokocimer, Mati Shaklai, HB Bassat, +3

Blood

Derivatives of butyric acid as potential anti‐neoplastic agents

Ada Rephaeli, Ester Rabizadeh, Adina Aviram, +3

International Journal of Cancer

The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders

N. Schoenfeld, Orit Epstein, Meir Lahav, +3

Cancer Letters

Lymphoid NeoplasiaHeme Biosynthetic PathwayAutoimmune DiseaseMalignant Lymphoproliferative DisordersMalignant Blood Disorder +9

Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas.

Osnat Bairey, Yael Zimra, Mati Shaklai, +2

PubMed

Hematological MalignancyTumor BiologyLymphoid NeoplasiaMedicineMalignant Blood Disorder +13

Rapid alteration of c‐<i>myc</i> and c‐<i>jun</i> expression in leukemic cells induced to differentiate by a butyric acid prodrug

Ester Rabizadeh, Mati Shaklai, Abraham Nudelman, +2

FEBS Letters

Myopathy, lactic acidosis, and sideroblastic anemia: A new syndrome

Aida Inbal, Nelly E. Avissar, Mati Shaklai, +5

American Journal of Medical Genetics